PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2025 Earnings Call Transcript
Operator: Greetings. Welcome to PDS Biotech Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Pds Biotechnology Corp (PDSB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 2,236,000 | $2,973,880 | -50% | 0.05% |
| 2. | Citadel Investment Group Ken Griffin | 249,025 | $331,203 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 105,687 | $140,564 | 0% | |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 97,765 | $130,027 | 0% | |
| 5. | Millennium Management Israel Englander | 81,449 | $108,327 | +61% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.66 | 15,060 | $24,999.60 | 61,213 | 2025-02-28 | Filing | |
| $1.66 | 15,061 | $25,001.26 | 78,851 | 2025-02-28 | Filing | |
| $9.00 | 100 | $900.00 | 4,075 | 2021-12-13 | Filing | |
| $9.00 | 100 | $900.00 | 3,975 | 2021-12-13 | Filing | |
| $8.90 | 400 | $3,560.00 | 3,875 | 2021-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.41 | 2,500 | $41,025.00 | 570,602 | 2018-03-22 | Filing | |
| $16.52 | 2,500 | $41,300.00 | 573,102 | 2018-03-21 | Filing | |
| $16.47 | 5,000 | $82,350.00 | 575,602 | 2018-03-20 | Filing | |
| $16.66 | 2,500 | $41,650.00 | 580,602 | 2018-03-19 | Filing | |
| $15.08 | 2,500 | $37,700.00 | 70,236 | 2018-03-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,951,343 | $2,595,286 | 0% | |
| 2. | 543,021 | $722,218 | 0% | |
| 3. | 514,391 | $684,139 | 0% | |
| 4. | 417,934 | $555,959 | 0% | |
| 5. | 250,000 | $332,500 | 0% |
News See All
PDS Biotechnology Corporation (PDSB)’s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial
PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the PDS Biotech's First Quarter 2025 Earnings Conference Call. [Operator Instructions].
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript
Operator: Good morning. And welcome to PDS Biotech's Fourth Quarter and Full Year 2024 Earnings Conference Call.
10 Penny Stocks With Huge Upside Potential According To Analysts
Penny stocks trade below $5 and attract investors looking for high returns with a small initial investment.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to PDS Biotech's Third Quarter 2024 Results and Clinical Strategy Update Conference Call. All participants are currently in listen-only mode.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to PDS Biotech's call to discuss the company's Year-End 2023 Financial Results and Clinical Strategy Update Conference Call.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to PDS Biotech's call to discuss the company's Year-End 2023 Financial Results and Clinical Strategy Update Conference Call.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the PDS Biotechnology Third Quarter 2023 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions].
PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the PDS Biotechnology Second Quarter 2023 Earnings Call and Webcast. If anyone should require Operator assistance, please press star, zero on your telephone keypad.